Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Lipocine (LPCN) over the last 12 years, with Q3 2025 value amounting to $14123.0.

  • Lipocine's Depreciation & Amortization (CF) rose 6593.82% to $14123.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $61372.0, marking a year-over-year increase of 8299.24%. This contributed to the annual value of $41106.0 for FY2024, which is 4342.14% up from last year.
  • Lipocine's Depreciation & Amortization (CF) amounted to $14123.0 in Q3 2025, which was up 6593.82% from $16108.0 recorded in Q2 2025.
  • In the past 5 years, Lipocine's Depreciation & Amortization (CF) registered a high of $16108.0 during Q2 2025, and its lowest value of $1719.0 during Q1 2022.
  • Over the past 4 years, Lipocine's median Depreciation & Amortization (CF) value was $8091.0 (recorded in 2023), while the average stood at $8334.7.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first surged by 21384.79% in 2023, then surged by 520.33% in 2024.
  • Lipocine's Depreciation & Amortization (CF) (Quarter) stood at $2578.0 in 2022, then soared by 210.43% to $8003.0 in 2023, then skyrocketed by 94.56% to $15571.0 in 2024, then fell by 9.3% to $14123.0 in 2025.
  • Its Depreciation & Amortization (CF) was $14123.0 in Q3 2025, compared to $16108.0 in Q2 2025 and $15570.0 in Q1 2025.